The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Paliperidone Krka 3 mg prolonged-release tablets



KRKA, d.d., Novo mestoPA1347/092/001

Main Information

Trade NamePaliperidone Krka 3 mg prolonged-release tablets
Active SubstancesPaliperidone
Dosage FormProlonged-release tablet
Licence HolderKRKA, d.d., Novo mesto
Licence NumberPA1347/092/001

Group Information

ATC CodeN05AX13 paliperidone

Status

License statusAuthorised
Licence Issued12/04/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0130-045-024
Interchangeable List DocumentPDF of Interchangeable List
« Back